GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase

Published:2005-05 Issue:5 Volume:22 Page:633-642
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Munn David H.,Sharma Madhav D.,Baban Babak,Harding Heather P.,Zhang Yuhong,Ron David,Mellor Andrew L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference42 articles.

1. Preservation of liver protein synthesis during dietary leucine deprivation occurs at the expense of skeletal muscle mass in mice deleted for eIF2 kinase GCN2;Anthony;J. Biol. Chem.,2004

2. Translational control in T lymphocytes;Beretta;Int. Rev. Immunol.,2004

3. Regulation of hemoglobin synthesis and proliferation of differentiating erythroid cells by heme-regulated eIF-2alpha kinase;Crosby;Blood,2000

4. Gene-specific regulation by general translation factors;Dever;Cell,2002

5. Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain;Dong;Mol. Cell,2000

Cited by 1039 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indoleamine 2,3-dioxygenase-1 involves in CD8+T cell exhaustion in glioblastoma via regulating tryptophan levels;International Immunopharmacology;2024-12

2. Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting;Translational Oncology;2024-11

3. IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth;Biomedicine & Pharmacotherapy;2024-10

4. General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases;Frontiers in Aging;2024-09-10

5. Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers;Cancers;2024-09-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3